242 filings
Page 9 of 13
8-K
gh9qhcr1sk
31 Aug 18
Entry into a Material Definitive Agreement
12:00am
424B5
wj8zfhv6 a5wmsecl
31 Aug 18
Prospectus supplement for primary offering
12:00am
8-K
upblsg0 45jo8jb9x3u
7 Aug 18
Reports Second Quarter 2018 Financial Results
5:10pm
8-K
s58n wgte
1 Jun 18
Departure of Directors or Certain Officers
5:05pm
S-8
6sv4jf1
1 Jun 18
Registration of securities for employees
4:09pm
8-K
qvzu77l3hontu vqd2
30 May 18
CRISPR Therapeutics and Vertex Provide Update on FDA Review of Investigational New Drug
4:37pm
8-K
9pw1chkn xr
8 May 18
Reports First Quarter 2018 Financial Results
7:43am
DEFA14A
a3wyzsq
18 Apr 18
Additional proxy soliciting materials
12:00am
8-K
5gndu9x93f8c
8 Mar 18
Reports Fourth Quarter and Full Year 2017 Financial Results
12:00am
424B5
aaim5
5 Jan 18
Prospectus supplement for primary offering
12:00am
8-K
8a7hulz96b0106ldnss
5 Jan 18
CRISPR Therapeutics Announces Proposed Public Offering of Common Shares
12:00am
424B5
gs2udlz d6dovmqam7t
3 Jan 18
Prospectus supplement for primary offering
12:00am
CT ORDER
3wjhl
21 Dec 17
Confidential treatment order
12:00am
8-K
z7vhb4 3a8ejyviqt
21 Dec 17
CRISPR Therapeutics Announces Appointment of Dr. Rodger Novak as Chairman of the Board
12:00am
8-K
jrsntzt4hhw6v1ubmpey
18 Dec 17
Vertex and CRISPR Therapeutics toCo-Develop andCo-Commercialize
12:00am